Newsfile Corp

IN THE PRESS

Biosenta Announces Closing of Previously Announced Transaction

February 22, 2024

·

1 min read

Adaptimmune to Report Q4 and Full Year 2023 Financial and Business Updates on Wednesday, March 6, 2024

February 22, 2024

·

2 min read

NervGen Pharma Grants Stock Options

February 21, 2024

·

1 min read

NervGen Pharma Recognized as a Top 50 TSX Venture Exchange Company

February 21, 2024

·

5 min read

Drug Development

Cardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis

February 21, 2024

·

7 min read

Marvel Biosciences Announces Testing MB-204 on Autism by French University

February 20, 2024

·

4 min read

BioHarvest Sciences Issues Clarification to February 15, 2024 News Release Announcing Engagement with IR Firm

February 20, 2024

·

5 min read

Cannabis Bioscience International Holdings, Inc. Announces Engagement of Bull in Advantage as its Investor Relations Firm

February 20, 2024

·

3 min read

American Aires Closes $4 Million Oversubscribed Private Placement

February 19, 2024

·

7 min read

Drug Development

NervGen Pharma on Track to Complete Enrollment, Deliver Data Readout in Phase 1b/2a Clinical Trial for NVG-291 in Spinal Cord Injury

February 15, 2024

·

10 min read

15 Toronto St., Suite 601 Toronto ON M5C 2E3 US

Tel: 416-806-1750